Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

INOCA May Be at the Root of Angina for Many Long-COVID Patients

Caitlin E. Cox

April 17, 2024

News Opinion CV Team Dispatch

January 2021 News Roundup

L.A. McKeown

January 01, 2021

News Conference News ESC 2020

In Long-term, Real-world Data, CABG Bests PCI for Diabetic Patients With MVD

Yael L. Maxwell

September 01, 2020

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

News Features

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

Caitlin E. Cox

April 23, 2020

News Daily News

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

Shelley Wood

March 29, 2018

News Daily News

Acute MI Quality Improvement Program Fails in India, but Researchers See Bright Side

L.A. McKeown

February 15, 2018

News Daily News

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

Caitlin E. Cox

October 27, 2015

News Industry News

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

August 31, 2015

News Industry News

Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

June 05, 2015

News Daily News

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

L.A. McKeown

March 20, 2014

News Conference News ESC 2013

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Caitlin E. Cox

September 04, 2013

News Daily News

Intracoronary ACE Inhibitor Reduces Microvascular Damage in Elective PCI

Yael L. Maxwell

January 06, 2013

News Daily News

Coronary Reactivity Testing Relatively Safe in High-Risk Women Without CAD

June 25, 2012

Advertisement

INOCA May Be at the Root of Angina for Many Long-COVID Patients

January 2021 News Roundup

In Long-term, Real-world Data, CABG Bests PCI for Diabetic Patients With MVD

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

Acute MI Quality Improvement Program Fails in India, but Researchers See Bright Side

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Intracoronary ACE Inhibitor Reduces Microvascular Damage in Elective PCI

Coronary Reactivity Testing Relatively Safe in High-Risk Women Without CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content